Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 104-29-0
2. 3-(4-chlorophenoxy)-1,2-propanediol
3. 3-(4-chlorophenoxy)propane-1,2-diol
4. Chlorophenesin
5. Adermykon
6. Gecophen
7. Demykon
8. Mycil
9. Chlorphenesinum
10. P-chlorophenyl Glyceryl Ether
11. Chlorphenesine
12. Clorfenesina
13. 1,2-propanediol, 3-(4-chlorophenoxy)-
14. 3-(p-chlorophenoxy)-1,2-propanediol
15. Clorfenesina [inn-spanish]
16. Chlorphenesine [inn-french]
17. Chlorphenesinum [inn-latin]
18. Glycerol Alpha-p-chlorophenyl Ether
19. P-chlorophenyl-alpha-glyceryl Ether
20. 3-(p-chlorophenoxy)propane-1,2-diol
21. Nsc 6401
22. 1,2-propanediol, 3-(p-chlorophenoxy)-
23. I670dal4sz
24. Chebi:3642
25. 2-chlorphenesin
26. Nsc-6401
27. Mfcd00021990
28. Glycerol .alpha.-p-chlorophenyl Ether
29. P-chlorophenyl-.alpha.-glyceryl Ether
30. Ncgc00160584-01
31. 1,2-propanediol, 3-(4-chlorophenoxy)- (9ci)
32. Gechophen
33. P-chlorophenyl
34. Chlorphenesin [inn:ban]
35. 3-(4-chlorophenoxy)propane-1,2-diol;3-(4-chlorophenoxy)propane-1,2-diol
36. Alpha-glyceryl Ether
37. Einecs 203-192-6
38. Unii-i670dal4sz
39. Brn 2210845
40. Ai3-24623
41. (+/-)-chlorphenesin
42. Maybridge1_000170
43. Chlorphenesin [mi]
44. Wln: Q1yq1or Dg
45. Chlorphenesin [inn]
46. Mixcom1_000324
47. 1, 3-(p-chlorophenoxy)-
48. Chlorphenesin [inci]
49. Dsstox_cid_28954
50. Dsstox_rid_83219
51. Dsstox_gsid_49028
52. Oprea1_755443
53. Schembl93836
54. Chlorphenesin [vandf]
55. 1, 3-(4-chlorophenoxy)-
56. 4-06-00-00831 (beilstein Handbook Reference)
57. Chlorphenesin [mart.]
58. Chlorphenesin [who-dd]
59. Chembl388751
60. Dtxsid0049028
61. Nsc6401
62. Hms3604n15
63. 3-p-chlorophenoxy-1,2-propanediol
64. Albb-025796
65. Hy-a0133
66. Tox21_113554
67. 4-amino-4-chlorobenzophenone
68. Ac-266
69. S6442
70. 1-(p-chlorophenoxy)-2,3-propanediol
71. Akos005203039
72. Db00856
73. Hs-0080
74. 3-(p-chlorophenoxy)-propane-1,2 Diol
75. Chlorphenesin 100 Microg/ml In Methanol
76. Bp-20218
77. Cas-104-29-0
78. Sy058281
79. C3659
80. Chlorphenesin 100 Microg/ml In Acetonitrile
81. Cs-0017448
82. Ft-0623711
83. C07928
84. D71194
85. Sr-01000944964
86. J-001139
87. Q5103226
88. Sr-01000944964-1
89. Z1348239594
| Molecular Weight | 202.63 g/mol |
|---|---|
| Molecular Formula | C9H11ClO3 |
| XLogP3 | 1.2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 202.0396719 g/mol |
| Monoisotopic Mass | 202.0396719 g/mol |
| Topological Polar Surface Area | 49.7 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 135 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Used, along with rest and physical therapy, to treat injuries and other painful muscular conditions. Investigated for use in trigeminal neuralgia (tic douloureux), a neuropathic disorder characterized by severe facial pain. Was investigated as a modulator of histamine release.
Chlorphenesin is a muscle relaxant. It blocks nerve impulses (or pain sensations) that are sent to the brain.
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
D - Dermatologicals
D01 - Antifungals for dermatological use
D01A - Antifungals for topical use
D01AE - Other antifungals for topical use
D01AE07 - Chlorphenesin
Absorption
Rapid and complete.
Hepatic. 85% of a dose excreted within 24 hours as the glucuronide metabolite.
2.3-5 hours
The mechanism of action of chlorphenesin is not well defined, and its effects are measured mainly by subjective responses. It is known that chlorphenesin acts in the central nervous system (CNS) rather than directly on skeletal muscle.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ABOUT THIS PAGE
A Chlorphenesin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorphenesin, including repackagers and relabelers. The FDA regulates Chlorphenesin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorphenesin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chlorphenesin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chlorphenesin supplier is an individual or a company that provides Chlorphenesin active pharmaceutical ingredient (API) or Chlorphenesin finished formulations upon request. The Chlorphenesin suppliers may include Chlorphenesin API manufacturers, exporters, distributors and traders.
click here to find a list of Chlorphenesin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chlorphenesin written confirmation (Chlorphenesin WC) is an official document issued by a regulatory agency to a Chlorphenesin manufacturer, verifying that the manufacturing facility of a Chlorphenesin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Chlorphenesin APIs or Chlorphenesin finished pharmaceutical products to another nation, regulatory agencies frequently require a Chlorphenesin WC (written confirmation) as part of the regulatory process.
click here to find a list of Chlorphenesin suppliers with Written Confirmation (WC) on PharmaCompass.
Chlorphenesin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chlorphenesin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chlorphenesin GMP manufacturer or Chlorphenesin GMP API supplier for your needs.
A Chlorphenesin CoA (Certificate of Analysis) is a formal document that attests to Chlorphenesin's compliance with Chlorphenesin specifications and serves as a tool for batch-level quality control.
Chlorphenesin CoA mostly includes findings from lab analyses of a specific batch. For each Chlorphenesin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chlorphenesin may be tested according to a variety of international standards, such as European Pharmacopoeia (Chlorphenesin EP), Chlorphenesin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chlorphenesin USP).
LOOKING FOR A SUPPLIER?
